The UK’s Competition Commission has says the country’s cement market is inherently uncompetitive and has proposed significant remedies to boost competition in the sector.

The UK’s Office of Fair Trading today announced four new director appointments.

Companies need to create ever-more holistic compliance programmes as competition authorities take a harder line on information exchange. Katy Oglethorpe in London.

Alex Potter of Freshfields Bruckhaus Deringer in London is chair of the GCR Live: 4th Annual Competition Law, Consumer Goods and Retail conference. He talks to GCR about the core competition law issues in the consumer goods markets today.

Antitrust enforcers must work with intellectual property regulators to cope with rapidly changing, high-technology markets, the head of the UK’s Office of Fair Trading said yesterday.

The UK’s Office of Fair Trading has referred a completed merger between two leading cinema chains to the Competition Commission.

Dechert has hired Shearman & Sterling’s Brussels managing partner Hans Jürgen Meyer-Lindemann as an antitrust partner. He will split his time between the Brussels and Frankfurt offices.

Winston & Strawn has promoted associate Fabio Falconi to of counsel in the firm’s London office.

Susan Bright today stepped down as global co-head of Hogan Lovells’ competition practice to become managing partner of the firm’s London office.

Allen & Overy has hired Alasdair Balfour as a partner in the firm’s London competition practice.

Norton Rose has promoted associates in its UK and South African competition practices.

Competition economist Patrick Smith has been promoted to partner. 

The UK’s Competition Commission has cleared the completed merger between consumer goods wholesalers Booker Group and Makro.

The UK’s Office of Fair Trading is the latest antitrust enforcer to challenge pay-for-delay patent settlements between branded and generic drug makers, issuing an abuse of dominance complaint against GlaxoSmithKline for entering into deals the agency says stifled competition for a prominent anti-depressant.